Cargando…

Invasive pneumococcal diseases in children and adolescents– a single centre experience

BACKGROUND: S. pneumoniae is a major cause of meningitis, pneumonia and sepsis in children. In 2006 universal pneumococcal vaccination was recommended in Germany for all children up to their second birthday. We have compared the prevalence and outcome of IPD at a single hospital before and after the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schnappauf, Christin, Rodloff, Arne, Siekmeyer, Werner, Hirsch, Wolfgang, Sorge, Ina, Schuster, Volker, Kiess, Wieland
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984689/
https://www.ncbi.nlm.nih.gov/pubmed/24625087
http://dx.doi.org/10.1186/1756-0500-7-145
_version_ 1782311468564217856
author Schnappauf, Christin
Rodloff, Arne
Siekmeyer, Werner
Hirsch, Wolfgang
Sorge, Ina
Schuster, Volker
Kiess, Wieland
author_facet Schnappauf, Christin
Rodloff, Arne
Siekmeyer, Werner
Hirsch, Wolfgang
Sorge, Ina
Schuster, Volker
Kiess, Wieland
author_sort Schnappauf, Christin
collection PubMed
description BACKGROUND: S. pneumoniae is a major cause of meningitis, pneumonia and sepsis in children. In 2006 universal pneumococcal vaccination was recommended in Germany for all children up to their second birthday. We have compared the prevalence and outcome of IPD at a single hospital before and after the introduction of vaccination. FINDINGS: 55 cases of IPD were identified over an 11 year period. Almost half of the patients were younger than 2 years of age. Most of the children were affected by pneumonia. The second highest incidence seen was for meningitis and sepsis. 17 patients exhibited additional complications. Significant pre-existing and predisposing disorders, such as IRAK 4 defect, ALPS or SLE were identified in 4 patients. Complete recovery was seen in 78% of affected children; 11% had a fatal outcome and 11% suffered from long term complications. Only 31% overall had been vaccinated. The most common serotype was 14. Serotypes not covered by any of the current vaccines were also found. Antibiotic treatment commenced with cephalosporins in over 90%. CONCLUSION: Frequency of IPD in our hospital did not decrease after initiation of the pneumococcal vaccination. This might be due to vaccinations not being administered satisfactorily as well as to poor education about the need of the vaccination. Pre-existing diseases must be monitored and treated accordingly and rare deficiencies taken into account when IPD takes a foudroyant course. In addition, antibiotic stewardship has been initiated at this hospital centre as a consequence of the high cephalosporin use detected in this study.
format Online
Article
Text
id pubmed-3984689
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39846892014-04-14 Invasive pneumococcal diseases in children and adolescents– a single centre experience Schnappauf, Christin Rodloff, Arne Siekmeyer, Werner Hirsch, Wolfgang Sorge, Ina Schuster, Volker Kiess, Wieland BMC Res Notes Short Report BACKGROUND: S. pneumoniae is a major cause of meningitis, pneumonia and sepsis in children. In 2006 universal pneumococcal vaccination was recommended in Germany for all children up to their second birthday. We have compared the prevalence and outcome of IPD at a single hospital before and after the introduction of vaccination. FINDINGS: 55 cases of IPD were identified over an 11 year period. Almost half of the patients were younger than 2 years of age. Most of the children were affected by pneumonia. The second highest incidence seen was for meningitis and sepsis. 17 patients exhibited additional complications. Significant pre-existing and predisposing disorders, such as IRAK 4 defect, ALPS or SLE were identified in 4 patients. Complete recovery was seen in 78% of affected children; 11% had a fatal outcome and 11% suffered from long term complications. Only 31% overall had been vaccinated. The most common serotype was 14. Serotypes not covered by any of the current vaccines were also found. Antibiotic treatment commenced with cephalosporins in over 90%. CONCLUSION: Frequency of IPD in our hospital did not decrease after initiation of the pneumococcal vaccination. This might be due to vaccinations not being administered satisfactorily as well as to poor education about the need of the vaccination. Pre-existing diseases must be monitored and treated accordingly and rare deficiencies taken into account when IPD takes a foudroyant course. In addition, antibiotic stewardship has been initiated at this hospital centre as a consequence of the high cephalosporin use detected in this study. BioMed Central 2014-03-13 /pmc/articles/PMC3984689/ /pubmed/24625087 http://dx.doi.org/10.1186/1756-0500-7-145 Text en Copyright © 2014 Schnappauf et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.
spellingShingle Short Report
Schnappauf, Christin
Rodloff, Arne
Siekmeyer, Werner
Hirsch, Wolfgang
Sorge, Ina
Schuster, Volker
Kiess, Wieland
Invasive pneumococcal diseases in children and adolescents– a single centre experience
title Invasive pneumococcal diseases in children and adolescents– a single centre experience
title_full Invasive pneumococcal diseases in children and adolescents– a single centre experience
title_fullStr Invasive pneumococcal diseases in children and adolescents– a single centre experience
title_full_unstemmed Invasive pneumococcal diseases in children and adolescents– a single centre experience
title_short Invasive pneumococcal diseases in children and adolescents– a single centre experience
title_sort invasive pneumococcal diseases in children and adolescents– a single centre experience
topic Short Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984689/
https://www.ncbi.nlm.nih.gov/pubmed/24625087
http://dx.doi.org/10.1186/1756-0500-7-145
work_keys_str_mv AT schnappaufchristin invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience
AT rodloffarne invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience
AT siekmeyerwerner invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience
AT hirschwolfgang invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience
AT sorgeina invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience
AT schustervolker invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience
AT kiesswieland invasivepneumococcaldiseasesinchildrenandadolescentsasinglecentreexperience